Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Acute Myeloid Leukaemia

Interventions

DRUG

AZD1152

intravenous

Trial Locations (7)

Research Site, Nagoya

Research Site, Yoshida-gun

Research Site, Fukuoka

Research Site, Maebashi

Research Site, Isehara

Research Site, Yokohama

Research Site, Chūō